CytoNiche is a 3D bionic cell technology company.
CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated and intelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 3, 2022 | Series B | ¥300M | 1 | Gaorong Capital | — | Detail |
Sep 3, 2020 | Series A | — | 1 | — | — | Detail |
Aug 23, 2019 | Series A | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gaorong Capital | Yes | Series B |
Beijing Shouda Tianji Fund | — | Series A |
C&I Capital | — | Series A |